Qingtong Zhou

Affiliations: 
USTC, Downingtown, PA, United States 
Area:
drug screening, drug design, aptamer design, SELEX in silico
Google:
"Qingtong Zhou"
Mean distance: 8.92
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhao F, Hang K, Zhou Q, et al. (2023) Molecular basis of signal transduction mediated by the human GIPR splice variants. Proceedings of the National Academy of Sciences of the United States of America. 120: e2306145120
Zhou Q, Liu X, Neri D, et al. (2023) Structural insights into the interaction of three Y-shaped ligands with PI3Kα. Proceedings of the National Academy of Sciences of the United States of America. 120: e2304071120
Zhao W, Han S, Qiu N, et al. (2022) Structural insights into ligand recognition and selectivity of somatostatin receptors. Cell Research
Lin G, Feng Y, Cai X, et al. (2021) High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist. Molecules (Basel, Switzerland). 26
Wang X, Cheng X, Zhao L, et al. (2021) Molecular insights into differentiated ligand recognition of the human parathyroid hormone receptor 2. Proceedings of the National Academy of Sciences of the United States of America. 118
Zhou Q, Guo W, Dai A, et al. (2021) Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening. Biomolecules. 11
Cong Z, Chen LN, Ma H, et al. (2021) Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor. Nature Communications. 12: 3763
Lu Y, Liu H, Yang D, et al. (2021) Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A Receptor Targeting the Sodium Ion Pocket. Acs Chemical Biology
Lin G, Liu Q, Dai A, et al. (2020) Characterization of a naturally occurring mutation V368M in the human glucagon receptor and its association with metabolic disorders. The Biochemical Journal. 477: 2581-2594
Wang YZ, Liu X, Way G, et al. (2020) An in vitro Förster resonance energy transfer-based high-throughput screening assay identifies inhibitors of SUMOylation E2 Ubc9. Acta Pharmacologica Sinica
See more...